Latest Updates on Tort Cases

Read our latest blog posts for valuable legal insights.

De Novo Design of Allosterically Switchable Protein Assemblies

Designing nanodevices that can change shape and function in response to molecular signals is a key objective in protein design...

Evolving & Expanding Integrated Platform Partnerships to Drive Access, Affordability & Outcomes

Several recent developments have caused many people in our industry to think differently about affordability and access. In July, GoodRx and Boehringer...

Silicosis Lawsuit Filed Against Artificial Stone Manufacturers, Distributors

Castillo indicates in the lawsuit that he worked in Los Angeles as a stone countertop fabricator and installer from 2000...

Virtual agents: The future of pharma education, engagement and insights

Virtual agents: The future of pharma education, engagement and insights This exclusive whitepaper dives into the cutting-edge applications of virtual...

The future of pharma marketing with Real Chemistry

Join us for an eye-opening conversation with Eric Solomon, Practice Leader for Paid Media activation at AI-industry innovator at Real...

Court Establishes Deadline for Paraquat Lawsuit Plaintiffs To Issue Subpoenas for Evidence of Use, Exposure

Given common questions of fact and law raised in complaints brought throughout the federal court system, the Paraquat lawsuits have...

Vaccinating Against Cancer Cells and Reprogramming the Tumor Microenvironment That Protects Them

By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech The tumor microenvironment (TME) is one...

HFA152a CDMO Capability: A Driver for Combination Product Optimization

HFA152a CDMO Capability: A Driver for Combination Product Optimization Discover how green propellants are paving the way for eco-friendly inhalers...

Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years

Oxbryta Clinical Trial Deaths Led to Recall Reports have suggested that Pfizer’s decision to recall and withdraw Oxbryta from the...
Scroll to Top